CD86 and neoplasm: In addition, we identified a new tumor‐associated macrophage subset named TAM‐C2, marked without CD86 expression (an important co‐stimulatory molecule for CD8+T cell activation), almost exclusively in patients with PCa, which is partly responsible for disease progression.